MKKGY.US Merck KGaA ADR

Healthcare Pharmaceuticals USA Stocks
111.25 USD
Close of Nov 16, 2026
23.27 34.19
Market cap
USD 71.9B
P/E
32.1x
P/B
2.08x
ROE
6.8%
Dividend yield
1.56%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is MKKGY.US undervalued?

Graham number
Price111.25
Graham value64.63
Premium72.1%

MKKGY.US trades 72.1% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Merck KGaA ADR fundamental analysis

No fundamental analysis for Merck KGaA ADR yet.

Merck KGaA ADR stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Merck KGaA ADR

Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomo…

Full company profile